COVID-19 vaccination in Israel.
作者信息
Muhsen Khitam, Cohen Dani
机构信息
Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
出版信息
Clin Microbiol Infect. 2021 Nov;27(11):1570-1574. doi: 10.1016/j.cmi.2021.07.041. Epub 2021 Aug 9.
Abstract
摘要
相似文献
1
COVID-19 vaccination in Israel.
Clin Microbiol Infect. 2021 Nov;27(11):1570-1574. doi: 10.1016/j.cmi.2021.07.041. Epub 2021 Aug 9.
2
Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
BMJ. 2021 Aug 26;374:n1931. doi: 10.1136/bmj.n1931.
3
Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study.
BMJ. 2021 May 13;373:n1088. doi: 10.1136/bmj.n1088.
4
The safety, immunogenicity, and efficacy of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: a randomized, open-label, active-controlled phase 3 trial.
Emerg Microbes Infect. 2024 Dec;13(1):2320913. doi: 10.1080/22221751.2024.2320913. Epub 2024 Feb 29.
5
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
6
Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
MMWR Morb Mortal Wkly Rep. 2022 Jan 21;71(4):139-145. doi: 10.15585/mmwr.mm7104e3.
7
Comparative safety analysis of mRNA and adenoviral vector COVID-19 vaccines: a nationwide cohort study using an emulated target trial approach.
Clin Microbiol Infect. 2024 May;30(5):646-652. doi: 10.1016/j.cmi.2023.12.010. Epub 2023 Dec 13.
8
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021.
MMWR Morb Mortal Wkly Rep. 2021 Nov 5;70(44):1553-1559. doi: 10.15585/mmwr.mm7044e3.
9
Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Lancet Infect Dis. 2022 Jan;22(1):56-63. doi: 10.1016/S1473-3099(21)00479-5. Epub 2021 Sep 9.
10
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
MMWR Morb Mortal Wkly Rep. 2021 Aug 27;70(34):1156-1162. doi: 10.15585/mmwr.mm7034e2.
引用本文的文献
1
Developing and validating a culturally tailored questionnaire to assess COVID-19 vaccine hesitancy in Israel's ultraorthodox Jewish population.
Hum Vaccin Immunother. 2024 Dec 31;20(1):2429233. doi: 10.1080/21645515.2024.2429233. Epub 2024 Dec 5.
2
COVID-19 Vaccine Safety Technical (VaST) Work Group: Enhancing vaccine safety monitoring during the pandemic.
Vaccine. 2024 Sep 17;42 Suppl 3(Suppl 3):125549. doi: 10.1016/j.vaccine.2023.12.059. Epub 2024 Feb 9.
3
Review of Israel's action and response during the COVID-19 pandemic and tabletop exercise for the evaluation of readiness and resilience-lessons learned 2020-2021.
Front Public Health. 2024 Jan 24;11:1308267. doi: 10.3389/fpubh.2023.1308267. eCollection 2023.
4
Trends in the Incidence of Cardiovascular Diagnoses and Procedures over the Years 2012-2021 in Israel: The Impact of the COVID-19 Pandemic.
J Clin Med. 2024 Jan 15;13(2):476. doi: 10.3390/jcm13020476.
5
Encouraging COVID-19 vaccination by focusing on anticipated affect: A scoping review.
Heliyon. 2023 Nov 18;9(12):e22655. doi: 10.1016/j.heliyon.2023.e22655. eCollection 2023 Dec.
6
Psychological distress during the COVID-19 pandemic: An integrative perspective.
PLoS One. 2023 Oct 26;18(10):e0293189. doi: 10.1371/journal.pone.0293189. eCollection 2023.
7
Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic.
Int J Infect Dis. 2023 Jul;132:72-79. doi: 10.1016/j.ijid.2023.04.395. Epub 2023 Apr 16.
8
Determinants of humoral immune response to SARS-CoV-2 vaccines in solid cancer patients: A systematic review and meta-analysis.
Vaccine. 2023 Mar 10;41(11):1791-1798. doi: 10.1016/j.vaccine.2023.01.072. Epub 2023 Feb 13.
9
Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East.
Vaccine. 2022 Oct 26;40(45):6549-6557. doi: 10.1016/j.vaccine.2022.09.052. Epub 2022 Sep 23.
10
Community engagement to support COVID-19 vaccine uptake: a living systematic review protocol.
BMJ Open. 2022 Sep 20;12(9):e063057. doi: 10.1136/bmjopen-2022-063057.
本文引用的文献
1
Association Between BNT162b2 Vaccination and Incidence of SARS-CoV-2 Infection in Pregnant Women.
JAMA. 2021 Aug 24;326(8):728-735. doi: 10.1001/jama.2021.11035.
2
Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
MMWR Morb Mortal Wkly Rep. 2021 Jul 9;70(27):977-982. doi: 10.15585/mmwr.mm7027e2.
3
Myocarditis Following Immunization With mRNA COVID-19 Vaccines in Members of the US Military.
JAMA Cardiol. 2021 Oct 1;6(10):1202-1206. doi: 10.1001/jamacardio.2021.2833.
4
A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020-February 2021.
Lancet Reg Health Eur. 2021 Aug;7:100130. doi: 10.1016/j.lanepe.2021.100130. Epub 2021 Jun 5.
5
Assessment of Effectiveness of 1 Dose of BNT162b2 Vaccine for SARS-CoV-2 Infection 13 to 24 Days After Immunization.
JAMA Netw Open. 2021 Jun 1;4(6):e2115985. doi: 10.1001/jamanetworkopen.2021.15985.
6
Myocarditis following COVID-19 mRNA vaccination.
Vaccine. 2021 Jun 29;39(29):3790-3793. doi: 10.1016/j.vaccine.2021.05.087. Epub 2021 May 28.
7
Transient Cardiac Injury in Adolescents Receiving the BNT162b2 mRNA COVID-19 Vaccine.
Pediatr Infect Dis J. 2021 Oct 1;40(10):e360-e363. doi: 10.1097/INF.0000000000003235.
8
[THE NEED FOR REDUCING DISPARITIES IN SARS-COV-2 IMMUNIZATION: THE ULTRAORTHODOX AND ARAB POPULATIONS IN ISRAEL].
Harefuah. 2021 May;160(5):285-290.
9
The Effectiveness of the Two-Dose BNT162b2 Vaccine: Analysis of Real-World Data.
Clin Infect Dis. 2022 Feb 11;74(3):472-478. doi: 10.1093/cid/ciab438.
10
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
Lancet. 2021 May 15;397(10287):1819-1829. doi: 10.1016/S0140-6736(21)00947-8. Epub 2021 May 5.
Zotero 插件